Open Access

ARTICLE

Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy

ENRICO CALIMAN^1,2, SARA FANCELLI^1,2, FEDERICO SCOLARI³, ADRIANO PASQUI⁴, CLARA MANNESCHI⁴, DANIELE LAVACCHI¹, FRANCESCA MAZZONI⁴, FRANCESCA GENSINI⁵, VALERIA PASINI⁶, CAMILLA EVA COMIN^2,7, LUCA VOLTOLINI^2,8, SERENA PILLOZZI^1,2,*, LORENZO ANTONUZZO^1,2,4

1 Clinical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy
2 Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy
3 Department of Health Sciences, University of Florence, Florence, 50134, Italy
4 Medical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy
5 Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, 50134, Italy
6 Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, 50139, Italy
7 Section of Surgery, Histopathology and Molecular Pathology, University of Florence, Florence, 50139, Italy
8 Thoracic Surgery Unit, Careggi University Hospital, Florence, 50134, Italy

* Corresponding Author: SERENA PILLOZZI. Email: